I am Frank Wagener and was born at our Radboudumc! I am molecular scientist and assistant professor at the department of Dentistry -Orthodontics and Craniofacial Biology. Here, we aim to better understand the wonderful world of the mouth. More specifically, our investigations are directed to the etiology of craniofacial diseases, such as cleft lip and palate and to attenuate fibrosis and scar formation. Hereto, we are working within the research theme Reconstructive and regenerative medicine.
When you were a kid what did you want to be when you grew up? Can you tell us something about your child years.
As a boy, I was playing a lot of street soccer and hockey and I was reading a lot of books. When I was young, I wished to become archaeologist and would like to go to Peru to find the hidden city Viracocha where the Inca’s supposedly had hidden their treasures when the Spanish came… However, the chance of getting a paid job in this field seemed very difficult, therefore I changed my mind. At holidays in e.g. Italy, however, I still enjoy visiting beautiful excavation sites and old treasures. Meanwhile, I decided to discover novel treasures within biology and to become molecular scientist.
What was your previous academic training, where did you study and why that study?I studied “Molecular Sciences” in Wageningen University, a mix between biology, chemistry and physics. When I did my internships, I moved more towards the direction of biology and everything came to life. I got completely hooked to research and became attracted to the more medical topics. I moved to New York (Rockefeller University and New York Medical College) and returned to finish my PhD at Radboudumc (tumor immunology/hematology) and did my postdoc at pharmacology and toxicology. Now, I work at the Dentistry department and still like to collaborate with other labs.
The RIMLS motto is: ‘Today’s molecules for tomorrow’s medicine’. What does this mean for you?This motto fits very well with our research. We have been investigating for instance the use of the endogenous molecule bilirubin for use as medicine for inflammatory conditions. This “old” molecule was always seen as toxic waste product (when in large quantities, it can cause kernicterus in newborn babies). However, following mild elevation we demonstrated that bilirubin acts as a potent antioxidant and anti-inflammatory mediator not only in vitro and in animals but also in humans. We are currently investigating the role of inflammatory networks and protective pathways on etiology and therapeutic strategies of congenital abnormalities as cleft lip and palate and on scar formation/fibrosis.
Who is your great example as scientists? And please give a motivation why.There are many inspirational scientists… I chose two of them who were not afraid to think outside the scientific mainstream : 1. Leonardo Da Vinci (almost smartest Italian, engineer and artist) who thought in the 15th century about flying, biking and submarines… 2. Polly Matzinger who works as shepherd and developed from there the ‘danger theory’ that stirred up the immunological world.
Which research discovery that you have made has made you most proud?We demonstrated that heme induces inflammation via adhesion molecule induction, whereas heme oxygenase reduces inflammation. This mechanism plays a role in a wide variety of inflammatory diseases and processes, including sickle cell disease, pathological pregnancies, wound repair and fibrosis. We are currently developing a novel model explaining how free heme or heme in complex discriminates between immunity and tissue survival by acting as either danger signal or tissue survival factor.
Given unlimited finance what experiment would you perform?We would be able to faster translate promising in vitro and in vivo basic science findings to the clinical setting.
What does your working area (desk, office) look like and what does it say about you (or your research)?Like a bomb exploded… I guess my research is always exciting and explosive..
However, with the current flex workplaces, I am now adapting to working in a pdf world with less paper... so the paper piles are shrinking slowly…
Nominate a colleague to be in the spotlight and what would you like to ask him or her?Ben Joosten; how is your storm chasing going?
What type of person are you, quick insights:
a) Mac or PC? : MAC
b) Theater or cinema? : Cinema
c) Dine out or dine in? : Dine out
d) Ferrari or Fiat? : I wish to change my Kungfu Panda with a Ferrari
e) Shopaholic or chocoholic? : Chocoholic
f) Culture or Nature : Both
Related news items
RIMLS award ceremony proudly presenting the winners16 January 2020
Several RIMLS researchers received an award and bonus during the New Year's drinks. See all photo's and the ENABLE aftermovie.read more
Stofwisselkracht grant for Daan Panneman and Richard Rodenburg16 January 2020
Daan Panneman & Richard Rodenburg have been awarded a Stofwisselkracht grant for their proposal “CRISPR/Cas9 knock-in complementation in fibroblasts of mitochondrial disease patients”. Together with Omar Tutakhel & Jan Smeitink they will investigate the possibility of using CRISPR/Cas9 knock-in.read more
The PRIDE Study Evaluation of online methods of data collection16 January 2020
In Paediatric and Perinatal Epidemiology RIHS researchers Marleen van Gelder and Nel Roeleveld described the recruitment methods and online data collection within the PRIDE Study, the largest Dutch birth cohort study.read more
Radboud Talks 2020 scientific pitch competition14 January 2020
The next edition of Radboud Talks will take place in the spring. During this academic pitch competition, young researchers will be given the opportunity to share their stories with a large audience. In a three-minute presentation, you will talk about your research in a fun and accessible manner.read more
Rubicon Grant for Sami Mohammed14 January 2020
Former RIMLS researcher Sami Mohammed, theme Renal disorders, received a Rubicon Grant from the Dutch Organisation for Scientific Research (NWO). The Rubicon program gives young, highly promising researchers the opportunity to gain international research experience.read more
Review Sanne Frambach accepted by Pharmacological Reviews13 January 2020
In this review entitled 'Brothers in arms: ABCA1 and ABCG1-mediated cholesterol efflux as promising targets in cardiovascular disease treatment', RIMLS researcher Sanne Frambach, describe the possibilities for stimulating cellular efflux.read more